|Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results|
A single injection of a microRNA therapeutic directed at a genetic target in the liver of hepatitis C patients produced a significant drop in viral load, according to interim results from an early-stage study announced Wednesday by Regulus Therapeutics ...
TheStreet.com - Wed, 22 Oct 2014 08:53
|Promising hepatitis C drug = 100% gain|
USA TODAY - Wed, 22 Oct 2014 14:33
|Regulus soars on promising--but early--results for its hep C contender|
FierceBiotech - Wed, 22 Oct 2014 06:46
|Regulus Therapeutics Soars 90% On Hepatitis C Treatment News|
Benzinga - Wed, 22 Oct 2014 07:41
|Regulus surges on early hepatitis C drug data|
Businessweek - Wed, 22 Oct 2014 10:48
|Why Regulus Therapeutics Inc. Stock More Than Doubled|
Nasdaq - Wed, 22 Oct 2014 13:15
|Prisons balk at Sovaldi's $84000 cost for hepatitis C treatment|
Nationwide, at least half a million inmates have chronic hepatitis C — and the net costs of treating them all with Sovaldi could exceed $30 billion, according to the new study in the Annals of Internal Medicine. The study concedes that funding Sovaldi ...
SFGate - Mon, 20 Oct 2014 17:18
|For inmates, pricey hepatitis C drug could make financial sense|
Stanford Medical Center Report - Mon, 20 Oct 2014 14:11
|Officials Say Hepatitis C Drug Too Pricey To Give to All Calif. Inmates|
California Healthline - Tue, 21 Oct 2014 07:02
|Expensive Sovaldi drug for hepatitis C still most cost-effective choice for U ...|
Tech Times - Wed, 22 Oct 2014 04:37
|Email For inmates, pricey hepatitis C drug could make financial sense|
ScienceBlog.com (blog) - Wed, 22 Oct 2014 04:05
|Gilead's $1000-a-pill hepatitis C drug may make financial sense for prisons|
San Francisco Business Times (blog) - Mon, 20 Oct 2014 14:11
|Giving pricey hepatitis drug to prisoners may be financially wise|
WHTC - Tue, 21 Oct 2014 14:11
|Hepatitis C support group ran up €250000 in travel expenses|
Around 1,000 women were infected with Hepatitis C after receiving the blood product which was negligently contaminated by the former Blood Transfusion Service Board. The virus attacks the liver and can cause death. In a statement, the HSE said it ...
Irish Independent - Wed, 22 Oct 2014 13:31
|Alcohol, kennels, manicures - Hep C group spending revealed|
Irish Times - Thu, 23 Oct 2014 01:25
|HSE audit finds Hep C support group spent money on angel card readings and ...|
RTE.ie - Wed, 22 Oct 2014 10:11
|HSE 'knew Hepatitis C group spent lavishly on booze and travel'|
Irish Mirror - Thu, 23 Oct 2014 09:30
|Positive Action director ran up €34k taxi bill|
Irish Examiner - Wed, 22 Oct 2014 17:00
|Positive Action: Irish taxpayers fund patient group's 'extravagant expenses'|
BBC News - Thu, 23 Oct 2014 04:03
|Prisoners with Hepatitis C Can't Get Expensive Drug that Actually Works|
Around 17,000 California prison inmates have debilitating and deadly Hepatitis C, which until recently was extremely hard to treat. But a new wonder drug, Sovaldi, has hit the market and one pill a day for 12 weeks puts an end to most of the suffering.
AllGov - Fri, 24 Oct 2014 08:00
|New Hepatitis C drug could be available shortly|
RTE.ie - Fri, 24 Oct 2014 04:28
|Costly Hepatitis Drug For Prisoners Financially Viable?|
Diabetes Insider - Fri, 24 Oct 2014 07:26
|Senate Lawmaker Eyes Hearing on the Cost of Hepatitis C Treatments|
Responding to the ongoing controversy over the prices for new hepatitis C treatments, U.S. Sen. Bernard Sanders (I-Vt.) will probably hold a hearing – possibly before the year ends – to examine how the cost is affecting the U.S. Department of Veterans ...
Wall Street Journal (blog) - Mon, 20 Oct 2014 08:20
|Will High Price Hurt Gilead Sciences' New Hep-C Drug?|
Barron's (blog) - Mon, 20 Oct 2014 11:51
|What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock|
Motley Fool - Mon, 20 Oct 2014 05:15
|Gilead: Stage Set For Rally (GILD)|
Seeking Alpha (registration) - Mon, 20 Oct 2014 05:33
|The Price of Progress in Hepatitis C Management|
The combination of sofosbuvir 400 mg once daily with pegylated interferon and ribavirin produced 90% SVRs at 12 weeks in treatment-naïve, genotype 1 patients with hepatitis C, and up to 96% in genotype 4 patients.8 The most common adverse events seen ...
AJMC.com Managed Markets Network - Fri, 24 Oct 2014 05:45
|Hepatitis C group paid €13000 for weekend of pampering|
It said that giving therapies to women at weekend conferences took away the stigma of having to fill out forms divulging they had hepatitis C in other venues. The letter said that "even in Dublin, some members have issues accessing a qualified nurse ...
Irish Independent - Fri, 24 Oct 2014 18:41
|Australia's rejection of costly new treatment sofosbuvir a 'death sentence for ...|
Liver experts at a conference on the Gold Coast have been warned Australia is on the verge of a catastrophic death spiral from Hepatitis C. Dr Miriam Levy, the director of gastroenterology at Sydney's Liverpool Hospital, told the conference on Thursday ...
ABC Online - Thu, 23 Oct 2014 03:14